Literature DB >> 11091561

Inhibitory Effect of the Angiogenesis Inhibitor O-(Chloroacetyl-carbamoyl)fumagillol(TNP-470) on Tumor Growth and Metastasis of Murine Mammary Tumor Cell Line (JYG-B)Inoculated in Female Nude Mice.

.   

Abstract

The effect of the potent angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol(TNP-470), a semisynthetic analogue of fumagillin on tumor growth and metastasis was studied using murine mammary tumor cells (JYG-B) inoculated into female nude mice. Injection of TNP-470 at 10 and 30 mg/kg doses, 3 times a week, until the end of the experiment (41 days)inhibited the s.c.inoculated primary tumor growth in a dose-dependent manner (45%and 65% in volume, respectively). TNP-470 at 30 and 60 mg/kg doses, 3 times a week, until the end of the experiment (35 days), reduced the weight of the i.p. inoculated total tumor mass of abdominal dissemination in a dose-dependent manner (54% and 76%, respectively). Pulmonary metastasis was found in all mice but TNP-470 significantly reduced the lung weight reflecting the total volume of the metastatic foci, and the numbers of metastatic foci in the liver and kidneys was reduced by TNP-470 treatment. These findings show that the angiogenesis inhibitor (TNP-470)has a strong inhibitory effect on tumor grwoth and metastasis in vivo.

Entities:  

Year:  1996        PMID: 11091561     DOI: 10.1007/BF02966970

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  20 in total

1.  Angiogenesis Inhibitor O-(Chloroacetyl-carbamoyl) fumagillol (TNP-470) Inhibits Tumor Angiogenesis, Growth and Spontaneous Metastasis of MKL-4 Human Breast Cancer Cells in Female Athymic Nude Mice.

Authors: 
Journal:  Breast Cancer       Date:  1994-12-30       Impact factor: 4.239

2.  New murine mammary tumor cell lines.

Authors:  J Morimoto; S Imai; S Haga; Y Iwai; M Iwai; S Hiroishi; N Miyashita; K Moriwaki; H L Hosick
Journal:  In Vitro Cell Dev Biol       Date:  1991-05

3.  Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent.

Authors:  M Kusaka; K Sudo; T Fujita; S Marui; F Itoh; D Ingber; J Folkman
Journal:  Biochem Biophys Res Commun       Date:  1991-02-14       Impact factor: 3.575

4.  Anti-angiogenesis: new concept for therapy of solid tumors.

Authors:  J Folkman
Journal:  Ann Surg       Date:  1972-03       Impact factor: 12.969

5.  Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth.

Authors:  D Ingber; T Fujita; S Kishimoto; K Sudo; T Kanamaru; H Brem; J Folkman
Journal:  Nature       Date:  1990-12-06       Impact factor: 49.962

6.  Analysis of experimental antiangiogenic therapy.

Authors:  H Brem; J Folkman
Journal:  J Pediatr Surg       Date:  1993-03       Impact factor: 2.545

7.  Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470).

Authors:  M Yamaoka; T Yamamoto; T Masaki; S Ikeyama; K Sudo; T Fujita
Journal:  Cancer Res       Date:  1993-09-15       Impact factor: 12.701

8.  Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines.

Authors:  M Yamaoka; T Yamamoto; S Ikeyama; K Sudo; T Fujita
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

9.  Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.

Authors:  L Holmgren; M S O'Reilly; J Folkman
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

10.  Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470, and mitomycin C on the growth and liver metastasis of human colon cancer.

Authors:  H Konno; T Tanaka; I Matsuda; T Kanai; Y Maruo; N Nishino; S Nakamura; S Baba
Journal:  Int J Cancer       Date:  1995-04-10       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.